Drugs such as Cobenfy could reshape the antipsychotic market, providing a more nuanced range of patient options.

The findings shed light on the molecular mechanism behind the drug levodopa (L-Dopa), widely used to treat Parkinson’s disease. A hallmark of the condition is progressively diminishing dopamine, which ...

Dopamine’s effects in the brain are mediated by postsynaptic ... The complementary roles of A2A and D2 receptors in the striatum may provide a mechanism whereby inhibitory regulation of D2 receptors ...